Navigation Links
Thermo Fisher Scientific Shares Applications of Targeted Next-generation Sequencing Panels in Neurodevelopmental Disorder Research
Date:7/17/2017

Neurodevelopmental disorders (NDDs) are clinically and etiologically highly heterogeneous and are characterized by a wide range of overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has been instrumental in accelerating the pace of discovery in the field of NDD research and testing.

However, designing a custom panel for disease research requires hours of up-front work involving literature searches to select the genes most appropriate for their research, often without any information about how the panel will perform in their lab.

In this educational webinar on Ion Torrent technology, participants will gain a better understanding of the utility of custom targeted gene panels in clinical research specifically in neurodevelopmental disorders research. They will watch a live demonstration of designing a custom gene panel from a database of pre-tested genes relevant in inherited disease research.

Speakers will discuss recent findings from a neurodevelopmental disorder study using custom gene panels. The purpose of this study was to define the pathogenic role of disease-causing candidate genes and develop molecular tools with potential for clinical utility. They will present their hands-on experience in utilizing Ion AmpliSeq On-Demand Panels, a custom panel solution that allows researchers to customize panels from a catalog of wet lab-verified genes most relevant in inherited disease research.

The team at Thermo Fisher Scientific has arranged to have two speakers for this event; Dr. Alessandra Murgia, an associated professor in the Department of Woman and Child Health at the University of Padova in Italy, and Francisco Hernandez-Guzman, senior product manager for Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific.

Murgia is a director of Laboratory of Molecular Genetics and associate professor of pediatrics in the Department of Neurosciences and Department of Woman's and Child's Health at the University of Padua. She is a member of the American Society of Human Genetics, European Society of Human Genetics, and Italian Society of Human Genetics. Her areas of interest include neurodevelopmental disorders, Intellectual Disability/Autism Spectrum Disorders, Early Onset Epilepsy, and Hereditary Deafness.

Hernandez-Guzman is a senior product manager for Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific. He manages the Ion AmpliSeq Custom product line, which includes oversight of the automated custom design creation process in Ion AmpliSeq Designer, custom design services and overall order intake. Francisco received his doctorate degree in biophysics from State University of New York at Buffalo, before receiving an MBA in marketing from The Rady School of Management at the University of California, San Diego.

LabRoots will host the event July 20, 2017, beginning at 8:00 a.m. PDT, 11:00 a.m. EDT, 5:00 p.m. CEST. To read more on this event, learn of the continuing education credits offered, or to register for free, click here.

For Research Use Only. Not for use in diagnostic procedures.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14510988.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Thermo Fisher Scientific Webinar to Introduce High Content Imaging and Analysis for Drug Discovery
2. Thermo Fisher Scientific Demonstrates Improved differentiation of Stem Cell-derived Neurons and Downstream Applications
3. Thermo Fisher Scientific to Showcase Advances in Flow Cytometry in New Webinar
4. Save with H-B Verification Thermometers Calibrated for Specific Applications
5. American Academy of Thermology’s Annual Meeting & Scientific Session Receives ACCME Accreditation, Adds New Speakers & Workshop
6. CosmosID Launches Metagenomic and Antibiotic Resistance Application in Thermo Fisher Cloud
7. USPTO issues patent for "Preservation by Vaporization" technology, allowing manufacture of thermostable vaccines and other fragile biopharmaceuticals
8. PositiveID Corporations Thermomedics Subsidiary Signs Deals with Five New Healthcare Products Distributors in January
9. For the First Time American Academy of Thermology Offers 2016 ATT Member Certification Qualification Course via Webinar on July 30 and August 6
10. Kalorama: Many Benefits for Thermo Fisher in Announced Affymetrix Acquisition
11. Due Diligence Report: PositiveID to Acquire Thermomedics - Small Cap Street
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & Cell ... team, including a new addition to the presidential line of succession, at the ... the Society's leadership team for a three-year term (2019-2021). , All five incoming members ...
(Date:4/8/2019)... ... 08, 2019 , ... US Capital Global Securities , an affiliate of ... in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline ... hypoactive sexual dysfunction disorder and is ready to begin phase 2b trials. In phase ...
(Date:4/4/2019)... ... 2019 , ... Biomeme, Inc. , a leading manufacturer ... solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ™. ... an English chemist and X-ray crystallographer who made significant contributions to the understanding ...
Breaking Biology Technology:
(Date:4/4/2019)... ... 2019 , ... Orbsen Therapeutics, a biotechnology company focused on ... move its base of operations from the National University of Ireland (NUI) Galway ... in Galway, Ireland. , “With four clinical trials in full swing and the ...
(Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
(Date:3/29/2019)... (PRWEB) , ... March 28, 2019 , ... In the ... not directly prescribe a path for this task. Despite this uncertainty, several manufacturers have ... of today. In the first part of this webinar, learn how analytical similarity is ...
Breaking Biology News(10 mins):